webinar register page

Webinar banner
CDC/IDSA Clinician Call
Date: Saturday, Sep. 24, 3 p.m. ET/12 noon PT (U.S. and Canada)

Topic: Updates & Emerging Issues on COVID-19 and Monkeypox

The agenda and details are below.

1. Welcome and Introductions
• Dana S. Wollins, DrPH, MGC
Vice President, Clinical Affairs & Practice Guidelines, IDSA

2. Topics and Featured Experts

I. COVID-19: Situation Update, Emerging Variants & Implications for Therapeutics:
• Pragna Patel, MD, MPH
Captain, U.S. Public Health Service
Chief Medical Officer (acting)
Coronavirus and Other Respiratory Diseases Division (proposed)
National Center for Immunization and Respiratory Diseases
U.S. Centers for Disease Control & Prevention

• Meghan E. Pennini, PhD
Therapeutics Director
Administration for Strategic Preparedness and Response
U.S. Department of Health and Human Services

II. Monkeypox: Clinical Characteristics and Treatment Options for Severe Disease:

Introductory Remarks:
• Agam Rao, MD, MPH
Poxvirus SME
CDC Multinational Monkeypox Response
U.S. Centers for Disease Control and Prevention

Case Presentations:
• Severe Monkeypox in a Patient With Newly Diagnosed HIV
Robert Atmar, MD, FIDSA
Professor, Medicine-Infectious Diseases, Baylor College of Medicine
Chief, Infectious Diseases; Ben Taub Hospital

• Encephalitis in a Patient With Severe Monkeypox
Matt Copeland, MD
Assistant Professor
Georgetown University Medical Center

• Ocular Monkeypox
Vivian Huang, MD, MPH
Assistant Medical Director
Office of Epidemiology and Data Services
Maricopa County Department of Public Health

Nelson Nicolasora, MD
Division of Infectious Diseases
Banner-University Medical Center Phoenix

3. Q&A and Discussion

**Please send your questions in advance to Deirdre Lewis at dlewis@idsociety.org.**
Oct 22, 2022 03:00 PM
Dec 3, 2022 03:00 PM
Time shows in
* Required information